MAPT and Alzheimer disease: Addressing this problem within the AD pathology, it is known that peripheral hyperinsulinemia is followed by an impaired signaling process within the brain (76), which accounts for the subsequent activation (dephosphorylated form) of GSK-3β, thus amplifying IR, amyloid β accumulation, and hyperphosphorylated Tau accumulation (77, 78).